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Abstract Introduction: Providing higher quality medical
care to workers with occupationallyassociated carpaltunnel
syndrome (CTS) may reduce disability, facilitate return to
work, and lower the associated costs. Although many
workers’ compensation systems have adopted treatment
guidelinestoreducetheoveruseofunnecessarycare,limited
attention has been paid to ensuring that the care workers do
receive is high quality. Further, guidelines are not designed
toenableobjectiveassessmentsofqualityofcare.Thisstudy
sought to develop quality measures for the diagnostic
evaluation and non-operative management of CTS, includ-
ing managing occupational activities and functional limita-
tions. Methods: Using a variation of the well-established
RAND/UCLAAppropriatenessMethod,wedevelopeddraft
quality measures using guidelines and literature reviews.
Next, in a two-round modiﬁed-Delphi process, a multidis-
ciplinary panel of 11 U.S. experts in CTS rated the measures
on validity and feasibility. Results: Of 40 draft measures,
experts rated 31 (78%) valid and feasible. Nine measures
pertained to diagnostic evaluation, such as assessing symp-
toms,signs,andriskfactors.Elevenpertaintonon-operative
treatments, such as the use of splints, steroid injections, and
medications.Elevenothersaddressassessingtheassociation
between symptoms and work, managing occupational
activities, and accommodating functional limitations.
Conclusions: These measures will complement existing
treatment guidelines by enabling providers, payers, policy-
makers, and researchers to assess quality of care for CTS in
an objective, structured manner. Given the characteristics of
previous measures developed with these methods, greater
adherence to these measures will probably lead to improved
patient outcomes at a population level.
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Introduction
Minimizing disability, inappropriate time off work, and
their economic sequellae remain major goals of occupa-
tional medicine. Several studies have demonstrated the
clinical and ﬁnancial beneﬁts of ergonomic, disability
management, and return-to-work interventions [1–3]. In
many states, workers’ compensation systems have adopted
guidelines to prevent workers from receiving treatments
that appear unnecessary, may delay return to work, or may
even be harmful. However, less attention has been paid to
ensuring that injured workers receive the basic, essential
medical care processes involved in making a correct
diagnosis, alleviating symptoms, and addressing activities
and functional limitations. Better quality medical care
would beneﬁt both workers and employers. In one ran-
domized controlled trial in Spain, improving medical care
for musculoskeletal conditions reduced time on temporary
disability by 37%, the percentage of temporarily disabled
workers going onto permanent disability by 50%, and total
costs (including disability and medical care) by 37% [4].
Given the potential beneﬁts to workers and employers,
several provider organizations and payers would like to see
quality assessment and improvement activities become
more routine in occupational medicine.
Carpal tunnel syndrome (CTS) should be a key target for
such activities because it is prevalent and costly, and
because there is indirect evidence of quality deﬁcits. CTS
affects three out of every 10,000 full-time workers [5]. For
each workers’ compensation claim for CTS, employers pay
a median of $1,468 to $11,941 (inﬂated to 2009),
depending on whether surgery is performed [6, 7]. Each
worker with CTS experiences a cumulative loss of future
earnings equal to $45,000 to $89,000 [8].
For patients with CTS, diagnostic evaluations and non-
operative management are highly variable, which may
indicate care is of inconsistent quality. Recommended
history and physical examination elements are performed
inconsistently [9, 10], and physicians differ in the criteria
they use to diagnose CTS [11]. This variability in care
appears to affect when patients receive a CTS diagnosis
and how long they stay off work. A Washington State study
found that half of workers’ compensation claims for CTS
were initially ﬁled for other conditions, and 20% of the
time the CTS was not diagnosed until more than three
months into the claim. Later diagnoses were associated
with longer disability [6].
To evaluate quality of care for occupational disorders
like CTS, speciﬁc quality measures are needed. Process-
oriented quality measures identify basic, well-established
care processes that patients should or should not receive
under speciﬁc circumstances. The purpose of such mea-
sures is not to advance the standard of care but rather to
make existing standards explicit and measurable. Although
guidelines and measures can both help to standardize and
improve care, guidelines cannot be used to measure quality
(other similarities and differences between guidelines and
measures are explored below). For an occupational con-
dition, a set of quality measures should consider both
medical and occupational issues, such as whether a
patient’s symptoms are associated with occupational
activities and how occupational activities should be mod-
iﬁed. Existing sets of measures, such as one set for back
pain, often neglect occupational considerations [12].
The objective of this study was to develop a set of
quality measures that can be used to objectively assess the
quality of the diagnostic evaluation and therapeutic
management of CTS, with an emphasis on issues speciﬁc
to occupational settings. We developed these measures
using a variation of the well-established RAND/UCLA
Appropriateness Method. A particular strength of this
method is that it considers available literature but is able
to overcome gaps in research evidence by rigorously
synthesizing the experience of expert clinicians [13].
Randomized controlled trials do not exist for most health
care processes [14], including for many aspects of care
for CTS [15]. In such circumstances, syntheses of clinical
expertise are a valid and important form of evidence. This
is demonstrated by the fact that, in several studies
addressing a variety of conditions, better adherence to
measures developed using RAND/UCLA Appropriateness
Method has been associated with improved patient out-
comes [16–18].
Materials and Methods
Measure development is a three-step process: (1) devel-
oping draft measures by integrating guidelines and litera-
ture; and (2) reﬁning and selecting measures, in this case
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123using a variation of the RAND/UCLA panel method; and
(3) testing the measures against a data source. We report
the ﬁrst two steps in this paper.
We also developed measures to assess the quality of
electrodiagnostic testing [19], whether carpal tunnel release
surgery is performed for appropriate indications [20], and
the quality of peri-operative management; these measures
are being reported elsewhere.
Developing Draft Measures
Developing draft measures was an iterative process
involving collaboration among a rheumatologist, a phys-
iatrist, two internists with expertise in quality measure-
ment, and two hand surgeons, as well as a project advisory
board that included ﬁve occupational medicine physicians.
First, we identiﬁed aspects of care relevant to improving
quality for CTS (for example, the initial physical exami-
nation) using relevant clinical practice guidelines and other
summary literature. We conducted a general literature
search on CTS, updated a 2004 search for relevant guide-
lines by searching MEDLINE and the National Guidelines
Clearinghouse, and accessed personal reference collections
[21]. Team physicians reviewed the guidelines and litera-
ture, chose care processes that are likely to affect patient
outcomes or that are widely recommended, then wrote draft
measures.
Next, directed MEDLINE searches were conducted to
identify evidence pertinent to the draft indicators. A ref-
erence librarian conducted the searches, and excluded case
reports and animal studies. The searches included the terms
carpal tunnel syndrome OR median neuropathy, with
additional MeSH terms for speciﬁc subtopics: diagnosis
(classiﬁcation, severity, history, occupation, and tests),
non-surgical treatment (therapy, drug therapy, rehabilita-
tion), and return to work issues (disability, ergonomic,
work). Team physicians sequentially reviewed titles,
abstracts, and articles to assess relevance to each draft
measure. Respectively, 1,635 citations were reviewed
pertained to the diagnosis of CTS, 475 to non-surgical
treatment, and 538 to return to work issues. Draft measures
were reﬁned, added, and deleted on the basis of search
results.
Next, physicians summarized, for each draft measure,
the evidence supporting the relationship between the care
process and patient outcomes, emphasizing the highest
quality evidence identiﬁed. Given most of the evidence was
not high quality, we used a simpliﬁed classiﬁcation
scheme: level 1, randomized controlled trial; 2, observa-
tional study; and 3, case reports, case series and expert
opinion. Where level 1 evidence was not available, the
summary described a chain of evidence or clinical
rationale.
Reﬁning and Selecting Measures
Methods for reﬁning and selecting quality measures were
based on the RAND/UCLA Appropriateness Method, a
multidisciplinary, two-round, modiﬁed-Delphi process that
enables researchers to obtain a quantitative assessment that
reﬂects the judgment of a group of experts. This method
(explained below) has been used previously to develop
quality measures for a wide variety of conditions and types
of care. Additional background information and technical
details about this method have been published previously
[13, 22]. The method has reproducibility consistent with
that of well-accepted diagnostic tests like screening
mammography—i.e., separate panels examining the same
topic have produced similar recommendations (kappas
0.51–0.83). Further, the measures developed using this
method have been shown to have content, construct, and
predictive validity, as evidenced by the fact that measures
have been consistent with the results of subsequent ran-
domized controlled trials or associated with improved
patient outcomes. For example, panel judgments about the
appropriateness of carotid endarterectomy were consistent
with the ﬁndings of a subsequent randomized trial [23]. For
arthroplasty of the knee and hip, adherence to measures
addressing the appropriateness of surgery was found to be
associated with improved quality of life [18]. For vulner-
able elders, adherence to quality measures developed using
this method was found to be associated with improved
survival [16].
To select panelists for the current study, we asked U.S.
specialty societies to recommend physicians who are
leaders in each specialty, and then we reviewed curriculum
vitae, interviewed candidates, and contacted references.
The panel had eleven members: an occupational medicine
physician, a neurologist, a physiatrist, a family physician, a
physical therapist, four hand surgeons (one with primary
board designation in plastic surgery and three in orthopedic
surgery), and two orthopedists. We chose this balance of
specialties because panelists rated many measures per-
taining to carpal tunnel release surgery as well as the
diagnostic evaluation and non-operative management.
Panelists represented a variety of geographic locations,
expertise, and both academic and community practice
settings.
The ﬁrst round of ratings involved having panelists rate
the measures at home. Panelists received the evidence
summaries, draft measures, ballots, and instructions. Dur-
ing the second round, panelists met in person and research
team members moderated discussions of each draft mea-
sure, the evidence, and ﬁrst-round ratings. We used a
modiﬁed-Delphi panel method, rather than a consensus-
panel method that forces agreement, to allow different
attitudes to be expressed and contend with one another and
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received a summary of the ﬁrst-round ratings for each
measure, including the median, standard error, his/her
rating relative to the distribution, and the analytic inter-
pretation. Panelists suggested modiﬁcations to deﬁnitions
of key terms and measures; these were adopted when a
majority voted to do so. After all opinions had been voiced
for a measure, panelists marked private, equally weighted
ballots.
For both rounds, panelists rated validity, feasibility,
and importance on 9-point scales (9 = highest). Validity
meant: (1) adequate scientiﬁc evidence or professional
consensus exists to support a link between the performance
of care speciﬁed by the measure and improved clinical
outcomes; and (2) based on the panelists’ professional
experience, health professionals with signiﬁcantly higher
rates of adherence to a measure would be considered
higher-quality providers [13]. Panelists also rated measures
for feasibility and importance to facilitate future users’
efforts to prioritize the measures. Feasibility meant the
potential ability to evaluate adherence to the measure using
medical records. Importance meant the magnitude of the
potential effect on patient outcomes.
As is standard for this method, ratings interpretations
included: valid = a median of 7–9 without disagreement;
not valid = a median of 1–3 without disagreement;
uncertain validity = a median of 4–6 or any median with
disagreement. Disagreement was deﬁned as three or more
panelists rating in the 1–3 range and three or more in the
7–9 range [13]. Measures were considered potentially
feasible if the median was 4 or above. There was no
minimum threshold for importance because this variable
was intended to help future users prioritize the measures.
Comparison with Occupational Medicine Guideline
An occupational medicine physician assessed how con-
cordant each passing measure was with the current occu-
pational medicine guideline from the American College of
Occupational and Environmental Medicine (ACOEM)
[24]. Observations were discussed with another physician
who also compared the measures and guidelines.
Pilot Testing
After identifying measures meeting the validity and feasi-
bility criteria, RAND/UCLA team members developed a
detailed tool for scoring the measures. For each measure,
an experienced research nurse and research associate
deﬁned relevant terms within the measures, the populations
or care eligible for the measure (the denominator), and
instances in which care can be considered to adhere to the
measure (the numerator). Timeframes for eligibility and
adherence were speciﬁed. The team also anticipated fea-
sibility issues, such as data elements that may be difﬁcult to
ﬁnd in medical records or that could require subjective
judgments by abstractors, and developed speciﬁc instruc-
tions to resolve them.
Pilot testing enabled us to examine feasibility issues and
preliminary rates of adherence to the measures. Feasibility
issues included the ease which relevant patients can be
identiﬁed, the availability of the medical records required
to assess eligibility for and adherence to individual mea-
sures, and the clarity and usefulness of the scoring tool.
The RAND/UCLA team pilot tested the measures and tool
in a large workers’ compensation provider organization
(Kaiser Permanente Northern California Regional Occu-
pational Health) and in a large workers’ compensation
insurance company (the California State Compensation
Insurance Fund). Six nurses and one physical therapist
(‘‘abstractors’’), who routinely perform claims reviews
within each organization, underwent a two-day training in
the use of the tool and scored several practice cases.
Finally, they reviewed records for a small sample of
patients who had been diagnosed CTS or conditions often
confused with CTS. Patients were randomly selected by
applying pre-speciﬁed criteria (time period and diagnostic
category) to administrative databases maintained by the
insurance company. The abstractors working for the
insurance company reviewed clinical records routinely
collected for claims processing. The abstractors working
for the provider organization reviewed electronic medical
records for each patient. During the training and pilot
testing, abstractors provided feedback on the tool. The pilot
test activities were approved by each of the institutional
human subjects’ protection committees; informed consent
was not required.
Results
There were 40 draft measures. During the second round of
the rating process, 30 measures were modiﬁed, 9 measures
did not meet validity criteria, one of these 9 was also
judged infeasible, and the remainder passed (31/40 mea-
sures passed, 78%).
Final Measures
Nine ﬁnal RAND/UCLA CTS measures (Table 1)
emphasized the initial evaluation of patients with hand and
forearm complaints; 11 considered non-operative treat-
ments such as splinting, steroid injections, and other
medications; and 11 pertained to addressing activities and
functional limitations.
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Measure title Measure text
Measures for the initial evaluation of hand and forearm symptoms
1. New symptoms characteristic of CTS
require detailed assessment
IF the progress notes document new paresthesias or numbness in the ﬁngers, THEN
at least two of the following should be noted at the initial evaluation of those
symptoms: (1) a verbal or pictoral description of the location of any pain,
numbness, or paresthesias (e.g., Katz hand diagram), (2) the quality of any pain,
(3) the duration of any pain, numbness, or paresthesias, (4) onset of pain,
numbness, or paresthesias
2. New symptoms characteristic of CTS
should lead to suspicion
IF a patient complains of any of the following symptoms: Paresthesias, numbness, or
tingling on 1st to 3rd ﬁngers or palm THEN a suspicion of CTS should be
documented in the medical record at the initial evaluation of those symptoms.
3. New hand or forearm pain requires
evaluation for ‘‘red ﬂags’’
IF patient complains of new hand or forearm pain THEN the progress notes should
document the presence or absence of at least one of the following ‘‘Red ﬂags’’ at
the same visit: (1) trauma, (2) deformity, including swelling, (3) fever
4. Symptoms inconsistent with CTS require
evaluation
IF patient complains of hand or forearm pain and also has any of the following: (1)
New fever, (2) New point tenderness, (3) New deformity, THEN at least one
diagnosis other than CTS should be evaluated at this visit
5. New CTS diagnosis requires assessment of
medical risk factors
IF the progress notes document a new diagnosis of CTS, THEN a history of at least
one of the following risk factors should be documented during the ﬁrst three visits:
(1) Rheumatoid arthritis, (2) Diabetes mellitus, (3) Hypothyroidism, (4)
Pregnancy, if female, (5) Chronic renal failure
6. New suspicion of CTS requires speciﬁc
physical examination
IF the progress notes document that CTS is suspected THEN at least one of the
following physical examination maneuvers should be documented at initial
evaluation: (1) Testing for sensory abnormalities in median nerve distribution, (2)
Testing for thenar muscle weakness, (3) Examination for thenar muscle atrophy
7. New suspicion of CTS requires evaluation
for overweight
IF the progress notes document that CTS is suspected THEN height and weight, or a
clinical judgment about the presence or absence of obesity/overweight, should be
documented at initial evaluation
8. Imaging should be used selectively for
suspected CTS
IF the progress notes document that CTS is suspected THEN MRI or ultrasound or
CT should not be the initial test for diagnosis unless a structural lesion is suspected
9. Symptoms should be monitored after new
diagnosis of CTS
IF patient is newly diagnosed with CTS during a visit THEN at each CTS-related
visit during the ﬁrst three months after presentation, patient should be asked about
changes in at least one of the following: (1) Pain or paresthesias in the median
nerve distribution, (2) Symptoms of weakness, such as dropping things, decreased
grip strength, etc.
Measures for the non-operative treatment of CTS
10. Splints should be placed in neutral
position
IF a patient with CTS is prescribed a splint, THEN the chart should document that
the splint was positioned so that the wrist is neutral (neither extension[10 degrees
or ﬂexed)
11. An attempt at splinting should last at least
six weeks
IF a patient with CTS is prescribed a neutral splint, THEN the split should be
prescribed for at least six weeks
12. NSAIDs should not be used for CTS IF a patient is diagnosed with CTS, THEN the patient should not be given NSAIDs
to treat CTS symptoms
13. Muscle Relaxants should not be used for
CTS
IF a patient is diagnosed with CTS, THEN the patient should not be given muscle
relaxants to treat CTS symptoms
14. Opioids should not be used for CTS IF a patient is diagnosed with CTS, THEN the patient should not be given opioids to
treat CTS symptoms
15. Diuretics should not be used for CTS IF a patient is diagnosed with CTS, THEN the patient should not be given diuretics
to treat CTS symptoms
16. Steroid treatment requires discussion of
risks
IF a patient with CTS is prescribed oral steroids or administered a steroid injection
of the carpal tunnel, THEN the medical record should document that risks of the
treatment were discussed
17. Discuss beneﬁts of surgery when offering
steroids to patients with severe CTS
IF a patient has severe CTS, THEN the patient should not be offered a steroid
injection or oral steroids without also documentation that the possibility of surgery
was discussed
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Measure title Measure text
18. Steroids for work-associated symptoms
require follow-up
IF steroid injection is performed or oral steroids are prescribed for CTS symptoms
that are thought to be work associated THEN physicians should document a
follow-up call to or visit with the patient within 4 weeks
19. Limit steroid injections to 4 IF a steroid injection of the carpal tunnel is performed for CTS, THEN no more than
4 steroid injections should be performed total per hand, unless the provider
documents that the patient has refused surgery
20. Lasers should not be used for CTS IF patients are diagnosed with CTS, THEN low-level laser therapy should not be
prescribed for or used in treatment
Measures for addressing activities and functional limitations potentially associated with CTS symptoms
21. New CTS diagnosis requires detailed
occupational history
IF the progress notes document a new diagnosis of CTS, THEN at least one of the
following pieces of history should be documented between the time of initial
evaluation of the CTS symptoms and the second visit after the diagnosis: (1.)
occupation including functional job duties, (2.) duration at given occupation, (3.)
whether symptoms improve or worsen at work
22. New CTS diagnosis requires assessment
of occupational factors
IF the progress notes document a new diagnosis of CTS, THEN during the ﬁrst three
visits, the presence or absence of at least one of the following factors should be
documented for occupational settings: (1.) mechanical force, (2.) vibration, and
(3.) frequent repetitive wrist movements
23. New CTS diagnosis requires assessment
of non-occupational factors
IF the progress notes document a new diagnosis of CTS, THEN during the ﬁrst three
visits, the presence or absence of at least one of the following factors should be
documented for non-occupational settings: (1.) mechanical force, (2.) vibration,
and (3.) frequent repetitive wrist movements
24. Exacerbating activities should be
identiﬁed when CTS limits functioning
IF a patient has a diagnosis of carpal tunnel syndrome and a provider documents that
occupational or non-occupational functioning is limited by it THEN the provider
should also document the speciﬁc job duties or non-occupational activities that are
associated with symptoms
25. Rationale for work-association should be
documented
IF a patient is diagnosed with CTS and is working outside the home THEN, by the
ﬁrst visit after the initial presentation, the medical record should document the
provider’s opinion regarding the probability that that the CTS is work associated
together with a rationale
26. Patients diagnosed with CTS should be
educated about the condition
IF carpal tunnel syndrome is newly diagnosed THEN within the ﬁrst four weeks, the
provider should document that they educated the patient about at least one of the
following: (1.) symptoms; (2.) treatments; (3.) prognosis; (4.) exacerbating factors;
(5.) the rationale for a judgment of work-association; (6.) that unnecessary time off
work may not beneﬁt the patient; (7.) work-site or work-activity modiﬁcations; or
(8.) other issues relating to their CTS
27. Exposures to vibration, force, and
repetition should be minimized
IF a patient has a diagnosis of carpal tunnel syndrome and a provider documents
exposure to any of the following: mechanical force, vibration, and frequent
repetitive wrist movements THEN, during the same visit, the provider should
document that they discussed activity modiﬁcation with the patient
28. Work-associated CTS symptoms require
prompt follow-up
IF a patient has CTS and symptoms are newly thought to be work associated THEN
they should be seen for a follow-up visit within 4 weeks of initial evaluation
29. Work status should be monitored when
CTS appears work associated
IF work associated carpal tunnel syndrome is newly diagnosed THEN the provider
should document whether or not the individual is currently working at each CTS-
related visit during the ﬁrst three months
30. Return to work after CTS-related
disability requires follow-up assessment
IF a patient diagnosed with CTS returns to work after being on temporary work
associated disability for more than four weeks, THEN, within four weeks of
returning to work, they should have a follow-up assessment at which the presence
or absence of occupational functional limitations is documented
31. Prolonged CTS-related disability should
trigger evaluation
IF a patient is off work for four or more weeks for carpal tunnel symptoms THEN
the presence or absence of one of the following: (1.) alcohol or substance abuse,
(2.) depression or anxiety, or (3.) other barriers to return to work, should be
documented in the medical record by the next visit
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feasibility ratings, and the highest level of supporting
evidence. For few, if any, of these measures was there a
large randomized controlled trial or high-quality observa-
tional study directly examining the effect of the care
described. Nevertheless, in each instance, there is con-
vincing chain of evidence or clinical rationale that supports
the practice. An ‘‘Appendix’’ provides the supporting
rationale and a summary of the relevant literature.
Comparison with Occupational Medicine Guideline
Seventeen measures (55%) are fully concordant with the
ACOEM guideline, ﬁve are somewhat concordant (16%),
the ACOEM guideline did not address content within eight
of the measures (26%), and one measure is discordant with
the guideline (3%) (see Appendix for list) [24]. This last
measure addresses the use of non-steroidal anti-inﬂamma-
tory agents (NSAIDs) for CTS symptoms.
Pilot Testing
Regarding feasibility issues, the provider organization
readily identiﬁed eligible patients using ICD-9 and CPT
codes and had no difﬁculty determining eligibility for and
adherence to the measures due to the organization’s elec-
tronic medical record system. However, the insurance
company had some difﬁculty identifying eligible patients
because it uses broad diagnostic categories rather than ICD-
9 and CPT codes, and also assessing eligibility for some
measures because its clinical records were incomplete. As
to the scoring tool, the research team made many changes
based on feedback from the seven abstractors. None of the
measures were eliminated due to feasibility concerns.
Regarding preliminary rates of adherence, the pilot
study included a total of 28 unique patients. Sixteen had
been diagnosed with CTS and 12 with upper extremity
disorders commonly confused with CTS. Twenty-four
patients were eligible for one or more measures. Care was
eligible for a measure a total of 559 times, and adhered to
the measures 419 times (an overall adherence rate of 75%).
Adherence rates were 66% for initial evaluation, 79% for
non-operative treatment, and 81% for management of
activities and functional limitations. These results illustrate
the ability to assess quality of care for CTS and should not
be considered representative of the care provided by these
organizations.
Discussion
This paper describes a set of measures that can be used to
objectively assess the quality of medical care for carpal
tunnel syndrome, with an emphasis on issues speciﬁc to
occupational settings. The measures address the diagnostic
evaluation and non-operative treatment of CTS, including
assessing causality and managing occupational activities
and functional limitations.
Quality measures that focus on care processes, as these
do, are sometimes confused with treatment guidelines
because they share development methods and clinical
content. However, quality measures and guidelines serve
complementary functions (see Table 3). Quality measures
are rigid, quantitative tools that distinguish higher and
lower quality care after the care has already been provided,
whereas guidelines offer information that practitioners may
or may not use during real-time clinical decision-making.
Measures effectively become mandatory when adherence
to them is used to assign penalties or rewards, as payers
often do in non-occupational settings. Measures, for this
reason, describe basic standards rather than best practices,
are silent when the appropriate approaches are uncertain,
and are used to assess quality at the population level.
Conversely, guidelines are generally designed to be ﬂexible
and advisory; therefore, they cannot be accurately or reli-
ably used as quality assessment tools because they permit
providers to use their experience when applying recom-
mendations to individual patients and address situations in
which there is uncertainty about the preferred approaches.
Finally, measures are scored in a systematic, highly
structured fashion to ensure consistent results [25]. Thus,
although occupational medicine guidelines exist for CTS
[24], quality measures are also needed.
As noted in the Introduction, both payors and workers
have substantial interests in improving the quality of care
for CTS due to the high prevalence and costs associated
with the condition. Two studies have demonstrated that
quality improvement programs promoting adherence to
treatment guidelines can decrease time off work and reduce
costs. A randomized controlled trial in Spain demonstrated
that improving care for workers with musculoskeletal
injuries, including CTS, can markedly affect disability and
its costs, saving eleven U.S. dollars per dollar invested [4].
A smaller Washington State program produced similar
results: disability costs were reduced by 30% by improving
adherence to treatment protocols and encouraging providers
to prescribe activity and plan for return to work [26]. The
savings could be even greater if the costs associated with
reduced worker productivity were considered, since CTS is
a common cause of absenteeism [27]. Thus, improving
quality of care for occupational disorders may represent a
unique ‘‘win–win’’ for workers and employers, the two
central stakeholders in workers’ compensation systems.
Efforts to monitor and improve quality of care have
already become commonplace in other aspects of the
United States healthcare system. Most hospitals are now
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Measure title Validity Feasibility Importance Evidence
Median
 N (%) of
Ratings[=7
Median
 N (%) of
Ratings[=4
Median level

Initial evaluation of hand and forearm symptoms
1. New symptoms characteristic of CTS require detailed
assessment
8 (2–9) 9 (82%) 8 (7–9) 11 (100%) 8 (6–9) 2
2. New symptoms characteristic of CTS should lead to suspicion 8 (7–9) 11 (100%) 8 (7–9) 11 (100%) 7 (5–8) 2
3. New hand or forearm pain requires evaluation for ‘‘red ﬂags’’ 8 (1–9) 10 (91%) 8 (1–9) 10 (91%) 8 (1–9) 3
4. Symptoms inconsistent with CTS require evaluation 8 (6–9) 10 (91%) 8 (4–9) 11 (100%) 8 (5–9) 3
5. New CTS diagnosis requires assessment of medical risk factors 8 (1–9) 9 (82%) 8 (7–9) 11 (100%) 8 (5–9) 3
6. New suspicion of CTS requires speciﬁc physical examination 8 (5–9) 10 (91%) 8 (4–9) 11 (100%) 8 (5–9) 2
7. New suspicion of CTS requires evaluation for overweight 7 (5–9) 9 (82%) 7 (7–9) 11 (100%) 6 (2–9) 3
8. Imaging should be used selectively for suspected CTS 8 (7–9) 11 (100%) 8 (8–9) 11 (100%) 7 (3–9) 3
9. Symptoms should be monitored after new diagnosis of CTS 8 (7–8) 11 (100%) 8 (7–9) 11 (100%) 7 (4–8) 3
Non-operative treatment of CTS
10. Splints should be placed in neutral position 8 (7–9) 11 (100%) 8 (5–9) 11 (100%) 7 (4–9) 1
11. An attempt at splinting should last at least six weeks 7 (1–8) 8 (73%) 7 (1–8) 11 (100%) 7 (1–8) 1
Certain medications should not be used for CTS
12. NSAIDs 7 (4–8) 9 (82%) 7 (6–9) 11 (100%) 7 (3–9) 1
13. Muscle Relaxants 7 (6–9) 10 (91%) 8 (6–9) 11 (100%) 7 (3–9) 3
14. Opioids 8 (7–9) 11 (100%) 8 (7–9) 11 (100%) 7 (3–9) 3
15. Diuretics 8 (2–9) 11 (100%) 8 (7–9) 11 (100%) 7 (2–9) 1
16. Lasers should not be used for CTS 8 (7–9) 11 (100%) 8 (3–9) 10 (91%) 7 (1–9) 1
17. Discuss beneﬁts of surgery when offering steroids to patients
with severe CTS
8 (6–8) 10 (91%) 8 (6–9) 11 (100%) 8 (5–8) 1
18. Steroid treatment requires discussion of risks 8 (6–9) 10 (91%) 8 (7–9) 11 (100%) 6 (3–9) 3
19. Steroids for work-associated symptoms require follow-up 7 (6–9) 10 (91%) 8 (7–9) 11 (100%) 7 (5–9) 3
20. Limit steroid injections to 4 7 (4–9) 10 (91%) 8 (5–9) 11 (100%) 7 (3–9) 3
Addressing activities and functional limitations potentially associated with CTS symptoms
21. New CTS diagnosis requires detailed occupational history 7 (2–9) 9 (82%) 7 (7–9) 11 (100%) 6 (2–9) 3
22. New CTS diagnosis requires assessment of occupational
factors
7 (5–9) 8 (73%) 8 (5–9) 11 (100%) 7 (5–9) 2
23. New CTS diagnosis requires assessment of non-occupational
factors
7 (5–9) 8 (73%) 8 (5–9) 11 (100%) 7 (5–9) 2
24. Exacerbating activities should be identiﬁed when CTS limits
functioning
7 (4–9) 6 (55%) 7 (6–9) 11 (100%) 7 (5–9) 3
25. Rationale for work-association should be documented 7 (4–8) 6 (55%) 6 (3–8) 9 (82%) 7 (4–9) 3
26. Patients diagnosed with CTS should be educated about the
condition
7 (5–9) 6 (55%) 7 (4–9) 11 (100%) 7 (5–9) 3
27. Exposures to vibration, force, and repetition should be
minimized
7 (3–9) 7 (64%) 7 (4–8) 11 (100%) 7 (4–9) 2–3
28. Work-associated CTS symptoms require prompt follow-up 8 (6–9) 10 (91%) 8 (5–9) 11 (100%) 8 (2–9) 3
29. Work status should be monitored when CTS appears work
associated
7 (5–9) 9 (82%) 7 (5–9) 11 (100%) 7 (5–9) 3
30. Return to work after CTS-related disability requires follow-up
assessment
7 (5–9) 6 (55%) 7 (6–9) 11 (100%) 6 (5–9) 3
31. Prolonged CTS-related disability should trigger evaluation 7 (6–9) 10 (91%) 7 (6–9) 11 (100%) 7 (6–9) 2–3
* The table lists measure titles. The actual text of the measures is provided in Table 1
 Validity Ratings[=7 indicated panelists thought the measure was valid. Feasibility Ratings[=4 indicated panelists thought the measure was
potentially feasible. Level of Evidence: 1 = randomized controlled trial, 2 = observational data, 3 = case series or expert consensus
J Occup Rehabil (2011) 21:100–119 107
123required to publicly report performance with regards to
acute myocardial infarction, heart failure, and pneumonia
[28]. The National Committee on Quality Assurance’s
Healthcare Effectiveness Data and Information Set (HE-
DIS) enables health plans to monitor and report the quality
of the care their enrollees receive. Because 90% of health
plans participate in the HEDIS program and employers
consider HEDIS scores in healthcare purchasing decisions
[29], health plans have ﬁnancial incentive to improve
quality of care. Comparable efforts to assess and improve
Table 3 Similarities and differences between process-oriented quality measures and clinical treatment guidelines
Process-oriented quality measures Clinical treatment guidelines
Deﬁnition Criteria used to evaluate components of an encounter
between a physician or another health care
professional and a patient, and for which variations in
adherence lead to differences in outcomes[36]
Systematically developed statements that assist
practitioner and patient decisions about
appropriate health care for speciﬁc clinical
circumstances [37]
Developers Non-proﬁt entities, government bodies, specialty
societies, researchers, payers
Non-proﬁt entities, government bodies, specialty
societies, researchers, payers
Development methods Systematic literature reviews coupled with work by
expert panels
Systematic literature reviews coupled with work by
expert panels
Proprietary or publicly
available
Either Either
Speciﬁes basic standards Yes Yes
Speciﬁes best practices No Yes
Discusses areas
of uncertainty
No Yes
Mandatory or advisory Effectively mandatory when used as a basis for
assigning rewards and penalties [25]
Advisory [25]
Rigid or ﬂexible Rigid. Focus on selected situations for which there are
clear ‘‘right’’ or ‘‘wrong’’ approaches [25]
Very ﬂexible, intended to inform provider
judgments and patient preferences [25]
Length Measures are very concise and precisely written
statements (1–2 sentences)
Guidelines can be long documents that include
details about development methods, systems for
classifying the evidence, summaries of research
evidence, rationales for consensus-based
recommendations, etc.
Supporting
documentation
Often extensive to ensure consistent interpretation of
the measures. Deﬁnes relevant terms, population
eligible for the measure, conditions for satisfying the
measure, instructions for interpreting the often
variable information in clinical data sources, etc.
Not needed.
Users Generally used by organizations (large provider
organizations or payers), researchers, or
representatives of government. Can be used by
individual providers for self-assessment, such as
during board recertiﬁcation activities
Generally designed to be used by individual
providers
Timing of use Generally after care has been provided (retrospective) Generally at the point of care (concurrent)
Target population Carefully deﬁned populations of patients relevant to
individual measures or sets of measures
Patients in a broad category deﬁned by the
possibility that they may have or develop a
particular condition, or may be a candidate for a
particular treatment
Use is systematic
or ad hoc
Highly systematic scoring of adherence to criteria.
Often used to assess care for a population or sample
thereof.
Ad hoc, not scored. Used to look up speciﬁc
questions as they arise.
Prevalence of use
in U.S. Healthcare
system
Ninety percent of health plans for non-occupational
settings participate in the HEDIS program [29].
Medicare assesses quality of care for all hospitals and
nursing homes [28]. Quality measures are used in
multiple other efforts to improve quality of care
nationally.
Physicians do not consistently incorporate clinical
guidelines into their decision making because of
lack of knowledge, barriers to guideline
implementation, and unfavorable attitudes toward
guidelines [38]
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123care could be undertaken for occupationally associated
disorders.
Provider organizations, payors, and others planning to
use these measures will need detailed speciﬁcations to
score them consistently. The research team has developed
and pilot tested a comprehensive scoring tool that will
support these efforts. This tool includes all of the mea-
sures, including those pertaining to electrodiagnosis and
surgery. RAND will make the reﬁned, ﬁnal tool available
for free on its website during the summer of 2010. Pro-
vider organizations may be in a better position to identify
eligible patients and assess quality than payors are. We
found this to be the case in our pilot study. Further, in
non-occupational settings, providers typically perform
these functions and report quality of care data to payers
(with oversight and validation activities to ensure the
integrity of the data).
Comparison with Occupational Medicine Guideline
Overall, we found substantial concordance between the
RAND/UCLA CTS measures and the ACOEM guideline, a
major occupational medicine guideline, although there are
notable differences. The RAND/UCLA measures disap-
prove of NSAIDs for CTS because a randomized controlled
trial showed no beneﬁts and these medications increase the
risks of gastrointestinal bleeding and myocardial infarction
[30, 31], whereas the ACOEM guideline considers NSA-
IDs to be an appropriate option. Also, the ACOEM
guideline addresses many important topics that, for reasons
discussed above, the measures omit.
For example, no measure deﬁnes the optimal method for
establishing a diagnosis of CTS. Many studies, guidelines,
and commentators have wrestled with this issue. Certain
approaches to history taking and physical examination
have higher speciﬁcities for CTS, using positive electro-
diagnostic tests as the gold standard. In turn, positive
electrodiagnostic tests increase the probability that patients
will respond to surgery [15]. However, as of yet, there
appears to be no clear consensus as to the ‘‘correct’’
approach to synthesizing this information into a clinical
diagnosis. Consequently, the quality measures address the
diagnostic evaluation for CTS, but not the diagnosis itself.
While the ACOEM guideline will be useful for
informing providers of the preferred means of caring for
patients with occupational CTS, the RAND/UCLA mea-
sures can be used to assess quality of care and monitor the
effectiveness of any improvement efforts. Individual pro-
viders can use these measures to evaluate the quality of the
care they provide. Periodic retrospective chart review is a
central component of the occupational and preventive
medicine maintenance-of-certiﬁcation processes [32, 33].
The RAND/UCLA CTS measures could be used in such
reviews. Practices with multiple providers can evaluate
quality for the practice and, if warranted, develop an
infrastructure that supports improvement. Organizational
efforts are particularly likely to be effective because they
leverage the contributions of many individuals, and they
enable systems to be established that make adherence
simpler. Finally, payors of compensation claims might
consider using these measures as a basis for referring
patients to higher-quality providers, or as a basis for
offering higher-quality providers greater remuneration.
Limitations
Quality measures do have limitations. Some important
aspects of care for patients with CTS are not amenable to
measurement. For example, patients can be sensitive about
discussing potential barriers to returning to work, such as
conﬂicts with supervisors, and some providers may con-
duct these discussions more effectively than others do. But
many important aspects of care can be measured. Also, for
each measure, unique clinical circumstances will warrant
exceptions to the rule. Justiﬁable exceptions are not prob-
lematical so long as sample sizes are sufﬁcient and
exceptions are rare and randomly distributed among pop-
ulations of patients.
These measures also have speciﬁc limitations. First, the
literature examining these practices is rather limited, and
most of the measures are based on expert consensus.
Musculoskeletal disorders suffer for a lack of large, high-
quality randomized controlled trials, and randomized con-
trolled trials are not feasible for all aspects of care. In the
past, this panel method has successfully overcome similar
limitations to the literature for osteoarthritis, rheumatoid
arthritis, arthroplasty of the knee and hip, and many other
clinical situations [18, 34, 35]. Second, the panel included a
higher proportion of surgeons than it would have if only
diagnosis and non-operative treatment were considered. To
mitigate this issue, we submitted the measures for each
topic to relevant subspeciality journals in occupational
medicine, neurology, and surgery, thereby ensuring that the
measures undergo peer review by experts in these respec-
tive disciplines.
Third, the ultimate test of measures’ validity entails
assessing whether better adherence is associated with better
patient outcomes. In September 2010, we are planning to
undertake a prospective study that will compare adherence
to these measures with patients’ symptoms, functional
status, time off work, and permanent disability ratings. We
expect to ﬁnd an association because associations have
been found for previous sets of measures developed using
the same methods. However, most quality measures in
wide use today have yet to be been tested in this fashion.
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123In conclusion, this project has developed 31 measures
that can be used to evaluate the quality of the care for
CTS. These measures appear to be the ﬁrst quality mea-
sures to address both medical and occupational issues;
therefore, they lay the groundwork for quality assessment
activities to be introduced in occupational settings. These
measures could be useful in a variety of efforts to improve
quality of care for patients with CTS, whether initiated
by providers, medical groups, payors, or policymakers.
Similar measures should be developed for other work-
associated disorders.
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Appendix: List of Measures, Rationales,
and Summaries of Relevant Literature
Quality Measures for Initial Evaluation of Hand
and Forearm Symptoms
History
The history plays a key role in assisting practitioners to
make a correct diagnosis. Although data relating speciﬁc
pieces of the history to improved patient outcomes is rel-
atively limited, there are key components of the history that
help to narrow the differential diagnosis and point toward
or away from CTS. Typically, patients with CTS have
symptoms of paresthesia and pain [39, 40]. Stevens et al.
[39]. identiﬁed 100 patients with symptomatic electrodi-
agnostically conﬁrmed CTS (159 hands) and found that the
vast majority of them reported paresthesias (78, 93, and
96% in the thumb, index and middle ﬁnger respectively).
Forty percent of them reported having pain in the hands
[39]. Other important pieces of history that have been
identiﬁed include the location of the pain, quality, duration,
and onset [41–45].
The Katz hand diagram is a self-administered diagram
where patients mark symptoms including pain, numbness,
tingling and decreased sensation. By comparing the
patient’s diagram against a classiﬁcation system for symp-
toms, physicians then determine whether the symptoms
reﬂect classic, probable, possible or unlikely CTS. In a
cohort study, sensitivity was 80% and speciﬁcity was 90%
compared to CTS as deﬁned by nerve conduction studies,
unequivocalresponsetocorticosteroidinjectionorimprove-
ment in symptoms after surgical release [44]. Subsequent
reviews have concluded that the Katz hand diagram is
among the better diagnostic tests for CTS [46, 47].
Because CTS is commonly confused with other condi-
tions that cause symptoms in the hand and forearm and an
incorrect diagnosis can lead to delays in treatment [48],
panelists felt that providers must recognize symptoms that
may represent CTS early on. CTS is most probable when
symptoms occur in the ﬁrst through third digits or on the
palm in the area of the thenar eminence [46].
Asking about and documenting ‘‘red ﬂags,’’ including
history of trauma, deformity and fever, assists with making
a diagnosis. Because such historical information is incon-
sistent with CTS, their presence necessitates an investiga-
tion of other conditions. These elements of care are
recommended by the American College of Occupational
and Environmental Medicine Guidelines [49].
Asking patients about activities associated with CTS
symptoms enables any exacerbating factors to be identiﬁed
and mitigated; this is discussed in the section below. In
addition, providers should ask patients whether they have
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because identifying the underlying disease may direct
therapy to improve CTS symptoms in some patients. Non-
occupational risk factors include connective tissue disease
(like rheumatoid arthritis), diabetes, hypothyroidism, osteo-
arthritis of the wrist and carpal bones, and pregnancy.
History of wrist fracture is also strongly associated with
CTS, and identiﬁcation of this risk factor would help focus
treatment on correction of anatomic changes that may be
causing CTS [50–54].
Physical Examination
Although providers employ many physical examination
ﬁndings and tests to evaluate for CTS, the current panelists
believed that an adequate physical examination would
include at least one of the following: assessing thenar
muscle strength, assessing sensibility in the median nerve
distribution, and checking for thenar muscle atrophy.
Reviews have identiﬁed thumb abduction testing and
testing for decreased sensitivity to pain in the median nerve
territory compared with ipsilateral ulnar nerve territory, as
having among the strongest evidence as good diagnostic
tests [46, 47]. Thumb abduction was tested by Kuhlman
et al. and found to have sensitivity and speciﬁcity of 66%
and de Krom et al. found a sensitivity of 39% and speci-
ﬁcity of 80% as compared to nerve conduction studies for
the diagnosis of CTS [47, 53]. Testing for median nerve
territory hypalgesia was evaluated by Golding et al. [55].; it
had a low sensitivity of 15% but a good speciﬁcity of 93%
as compared to nerve conduction studies [55]. Kuhlman
et al. demonstrated a sensitivity of 51% and speciﬁcity of
85% as compared to nerve conduction studies [47]. Pooling
the results of the last 2 studies produced a positive likeli-
hood ratio of 31 (95% conﬁdence interval 2.0–5.1) and
negative likelihood ratio 0.7 (95% conﬁdence interval
0.5–1.1). In contrast, widely performed tests like Phalen’s
and Tinel’s actually have poor ability to predict the diag-
nosis of CTS as deﬁned by nerve conduction studies [46].
Given studies evaluating the various maneuvers are
somewhat limited, the panelists felt that any maneuvers
assess thenar muscle strength and sensibility in the median
nerve territory would be acceptable.
Thenar atrophy is not particularly sensitive or speciﬁc
for CTS but it is important to document because it is a
marker for more severe CTS. Indeed, our panelists deﬁned
severe carpal tunnel syndrome by the presence of thenar
atrophy. Many surgeons consider the presence of thenar
weakness or atrophy to be an indication for a surgical
release. For example, new treatment guidelines from the
American Academy of Orthopedic surgeons consider early
surgery an option when patients have clinical evidence of
median nerve denervation [56]. Studies are equivocal on
whether this ﬁnding is with worse outcomes following
carpal tunnel release [57–59].
In addition to the above physical examination maneu-
vers of the hand and wrist itself, determining whether the
patient may be overweight or obese is important because
several articles have linked increased body mass index with
CTS [50, 60].
Imaging
Because nerve conduction studies have high degree of
sensitivity and speciﬁcity for the diagnosis of CTS if per-
formed per the American Association of Electrodiagnostic
Medicine guidelines, they should be the primary test to
assist with the diagnosis of CTS. Radiographs, MRI, and
CT can be considered if space-occupying lesions or frac-
tures are suspected; existing literature does not support the
routine use of imaging tests for patients with CTS [41, 61,
62].
Follow-up
Panelists concluded that, during any follow-up visit in the
three months after CTS is diagnosed, when symptoms and
functional status are undergoing the most changes [63],
patients should be asked about symptoms of pain, pares-
thesias and weakness in the median nerve distribution in
order to assess how the patient is doing compared with
their initial presentation. A signiﬁcant proportion of
patients treated with conservative therapy (non-surgical
treatments) will progress and may need surgery [64–66].
They did not stipulate when follow-up visits must occur for
patients without work-associated CTS; work-associated
CTS is discussed below.
Quality Measures for Non-Operative Treatment
Splinting A poorly made, positioned, or used splint can
cause more problems than it solves. While many pre-fab-
ricated splints come out of the box in a position of 20–30
degrees of wrist extension, this is not the position preferred
for immobilization of the carpal tunnel structures. The
provider must fabricate or reposition the splint to neutral.
Use of a wrist splint in extension actually increases pres-
sure within the carpal tunnel relative to use of splints in a
neutral position [67].
Use of the splint for at least six weeks (or as long as
symptoms persist) improves outcome (decreased pain,
improved function) compared with less persistent, more
intermittent use. Two randomized, controlled trials have
examined the effectiveness of splinting and the timing of
use associated with improvement. Werner randomized 112
autoworkers with possible, probable, and deﬁnite carpal
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or pain in the distribution of the median nerve from hand
diagram score) to treatment with ergonomic education
alone or custom wrist splint worn at night for six weeks
[68]. The splinted group had a signiﬁcant reduction in
wrist, hand, and/or ﬁnger discomfort and improvement in
the Levine symptom severity scale. In a randomized study,
Walker et.al. studied 30 hands of 21 veterans with elect-
rodiagnostic demonstrated carpal tunnel syndrome and
compared night-only versus full-time use of custom neutral
wrist splint. The full-time use group reported more
improvement than the overnight group on the Levine
symptom severity scale, and such improvement was also
noted in improved sensory distal latency in the full-time
group [69].
Medications
The panelists concluded that diuretics, NSAIDs, opioids,
and muscle relaxants are inappropriate therapies for CTS
symptoms. Diuretics and NSAIDs provide no symptomatic
relief to patients with CTS compared with placebo. Chang
et.al. evaluated 73 patients with mild to moderate carpal
tunnel syndrome conﬁrmed electrodiagnostically and ran-
domized them to receive placebo, a diuretic (trichlo-
rmethiozaide), an NSAID (tenoxicam-SR) or oral steroids
(prednisolone) for four weeks. Patients who received
diuretics, NSAIDs, or placebo had no change in their
symptoms relative to baseline [70]. Given these ﬁndings
and the risks of gastrointestinal bleeding and myocardial
infarction, the risks of using NSAIDs outweigh the
potential beneﬁts for carpal tunnel syndrome [71]. There is
no evidence that opioids, or muscle relaxants relieve carpal
tunnel syndrome symptoms and the panelists noted that
they too may harm patients.
Several studies demonstrate that locally injected or oral
steroids appear to beneﬁt patients with carpal tunnel syn-
drome [64, 70, 72–74]. One randomized, controlled trial
demonstrated the two delivery modalities have similar
efﬁcacy [74]. However, due to the attendant risks of each,
the panelists felt that offering these treatments to patients
should be optional, not mandatory. Further, for all patients
offered steroids, a full discussion of the beneﬁts and risks
of the steroid injections should occur prior to proceeding
because the patient should be actively involved in his or her
care. The principle of informed consent relies on the
patient’s full understanding of beneﬁts and risks of any
medical treatment prior to it undertaking. Although the
risks are not common, they include median nerve injury,
(digital ﬂexor) tendon rupture, bleeding, infection, and
reﬂex sympathetic dystrophy [75, 76].
For patients with severe CTS, a randomized, controlled
trial demonstrated that steroid injections do not have
lasting beneﬁts and surgery is more effective. Thus pro-
viders should discuss the possibility of surgery as an
alternative to steroid injections. Gelberman et al. demon-
strated that for patient with severe CTS, only 4 patients out
of 32 had complete relief of symptoms at 18 months after
steroid injection as compared with 7 out of 18 in the mild
to moderate CTS group [77]. A more recent study dem-
onstrates that outcomes are superior with release than with
splinting [78]. The data on whether steroid injections or
surgery is superior in improving CTS symptoms among
patients without thenar atrophy is conﬂicting [75, 79].
If a patient does receive steroids either orally or via
injection, a physician should call or see the patient to
inquire about adverse effects and any response to treat-
ment. If the patient notes no improvement, reassessment of
whether the initial diagnosis was correct or consideration
of other therapies is warranted. The panelist felt that such
contacts with patients are generally recommended, but that
they are essential when the CTS appears work-associated
(i.e., the symptoms worsen during or after work) and that
the follow-up contact should occur no later than 4 weeks
after the initiation of treatment.
Steroid injections are not without risk and multiple
repeated injections are less likely to confer beneﬁt. Wong
et al. randomized 40 patients to either to single steroid
injection or 2 steroid injections 8 weeks apart. At
10 months, there were no differences in symptoms between
the two groups [80]. Per the Quality Standards Subcom-
mittee of Academy of Neurology, no more than 3 steroid
injections should be attempted [41]. The current panel felt
that the maximum number that would be acceptable was
four, which allows for additional extenuating circum-
stances for some patients.
Lasers
A randomized controlled trial has demonstrated that low-
level lasers are not effective in decreasing symptoms in
patients with CTS [81].
Quality Measures for Addressing Associated Activities
and Functional Limitations Potentially Associated
with CTS Symptoms
There are two basic reasons that patients with CTS may
need to change their activities at work or at home. First,
some activities can exacerbate the CTS symptoms. Second,
CTS, or its treatment, may lead to functional limitations,
deﬁned as any major activities the patient cannot do now
but could do before the CTS symptoms started. Both an
association with symptoms and functional limitations can
create the need for patients to completely eliminate certain
activities (‘‘activity restriction’’), or to modify how they
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activity restrictions can be achieved either by eliminating
the speciﬁc job tasks involving those inciting factors or, if
necessary, by placing the individual on disability. Activity
modiﬁcations can permit an individual to more safely
perform a task that involves exposure to a known inciting
factor Both occupational and non-occupational activities
are important because all exposures to inciting factors need
to be identiﬁed and mitigated, and because CTS can
adversely affect functioning in both occupational and non-
occupational settings [82, 83].
History of Associated Activities and Functional Limitations
AskingpatientswithCTSsymptomsaboutthenatureoftheir
occupation is important so that high risk occupations and
tasks can be identiﬁed, and job modiﬁcations can be imple-
mented. For example, occupations associated with higher
prevalenceofCTSincludeelectricalassembly,foodpacking
andprocessing,frozenfoodpackaging,andpoultryworkers,
among others [84]. Detailed information on the patient’s
functional job duties, duration of current employment, and
the timing of the symptoms relative to work activities are
important to determining whether a workers’ compensation
claim may be appropriate. The panelists felt that a minimum
standardofcareincludeddocumentingoneofthesepiecesof
occupational information.
Of the many factors that researchers have examined for
an association with CTS, mechanical force, vibration, fre-
quent repetitive movements or some combination of
the three appear to be most strongly associated [84–86].
Silverstein et al. evaluated 652 industry workers (in 39
different jobs from seven industrial sites) and categorized
their work as by force and repetitiveness and screened them
for CTS by symptoms and physical exam. They found that
high repetitiveness was a risk factor for CTS and the
combination of high force and high repetitiveness also
increased risk for CTS [87]. Cannon et al. in a case control
study, found that use of vibratory tools was associated with
CTS with an odds ratio of 13.8 [88]. The panelists con-
cluded that a minimum standard of care entailed assessing
whether any such exposures are present for both occupa-
tional and non-occupational settings, since people may
engage in hobbies, sports, or other non-employment-related
activities that exacerbate CTS symptoms.
In addition to associated activities, functional limitations
are also important because they are symptoms that reﬂect
the severity of the condition and how well patients are
responding to therapy [82, 83]. Limitations can be occu-
pational, such as an inability to perform speciﬁc job
tasks[82, 83]; or non-occupational, such as difﬁculties
turning keys, opening jars, buttoning clothes, etc. [89–91].
When limitations are present, the speciﬁc nature of the
limitations must be understood in order to formulate rec-
ommendations for modifying activities and to monitor
responses to therapy over time. The panelists concluded
that a basic standard of care is for providers to document
the speciﬁc functional job duties or non-occupational
activities that the patients cannot perform.
Judgments of Work Association
Assessing and documenting the likelihood that CTS is
work associated is not only consistent with the expectations
of State and Federal governments but also beneﬁts patients
[92–94]. Individuals with work-related CTS are entitled to
medical beneﬁts under workers’ compensation systems. If
a treating healthcare professional does not assess whether
an individual patient’s CTS is work-related, then that
provider would be less likely to recognize when a workers’
compensation claim is appropriate. Administrative delays
occur when treating healthcare professionals fail to make
judgments about causation, or fail to provide a rationale for
the judgments. Such delays can prevent patients from
receiving necessary care in a timely fashion, which can
prolong their CTS symptoms [95]. Thus, healthcare pro-
fessionals treating patients with CTS have a basic respon-
sibility to document their opinion as to the likelihood that
the CTS is work-related together with a rationale. Several
prior panels have come to this conclusion, as did the cur-
rent panel [49, 96, 97].
Patient Education and Activity Modiﬁcation
Patient education is an important component of any ther-
apeutic treatment plan because it supports patient adher-
ence to provider recommendations, helps patients to
navigate the healthcare and workers’ compensation sys-
tems, and enables patients to play a more active role in
managing their recovery. This assertion is supported by the
fact that patients’ conﬁdence in their ability to function
despite having CTS was a signiﬁcant predictor of return to
work and work-role functioning in the studies described
above [98, 99]. As with any condition, patients should be
provided with basic information about common symptoms
and treatments as well as prognosis. In addition, patients
with CTS should be advised to avoid well-established
inciting factors; such as vibration, mechanical force,
frequent repetitive movements, and awkward postures;
since such exposures are common in occupational and non-
occupational settings [86]. An American College of
Occupational and Environmental Medicine position state-
ment makes several recommendations regarding work-
associated CTS [100]. When providers judge CTS to be
work-associated, patients need to understand the rationale
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and will need this information to navigate the workers’
compensation system. Since patients may not realize that
unnecessary time off work is often not in their best interest,
they should be apprised of this. When work-site or work-
activity modiﬁcations are recommended, providers should
make it clear that patients are responsible for communi-
cating these recommendations to their employers. Lastly,
when patients are well enough to safely return to work, they
should be informed of this. The current panelists recognized
that each of these types of education is helpful, and felt it is
essential that some patient education occur. When an
exposure to vibration, mechanical force, or frequent repet-
itive movements is present, panelists felt that patients must
be instructed in modifying their activities to avoid the
exposure.
Follow-up
The current panelists concluded that follow-up must occur
promptly for patients with work-associated CTS. Although
no studies have directly evaluated the effect of having
regular follow-up on patient outcomes, several guidelines
have made recommendations, which vary from every
3–5 days [49], to every two weeks [97], to at least once
within six months [41]. The current panel considered fol-
low-up within four weeks of the initial evaluation to be a
minimum standard of care applicable to all patients with
work-associated CTS (including those not off work).
During the ﬁrst three months after CTS is diagnosed,
when disability and functional status undergo the greatest
changes [63], it is essential for providers to document whe-
ther or not patients are working. For patients who are on
temporary disability, documenting that they have not yet
returned to work is necessary in order to determine when
returning wouldbeappropriate.Among patients whoarenot
placed on disability, monitoring work status is an important
component of monitoring functional status, and is part of
monitoring exposure to any occupational inciting factors.
After individuals with CTS return to work following a
prolonged period of temporary disability, their CTS needs
to be reassessed [97]. The current panel concluded that, at a
minimum, providers should also document whether the
patient is experiencing any functional limitations at their
place of work, so that treatments or job tasks can be
modiﬁed, if necessary.
Table 4 Comparison of RAND/UCLA CTS quality-of-care measures with the ACOEM guideline [49]
RAND/UCLA measure title Concordance with
ACOEM guideline
Comments
1. New symptoms characteristic of CTS require
detailed assessment
Concordant
2. New symptoms characteristic of CTS should lead
to suspicion
Concordant
3. New hand or forearm pain requires evaluation for
‘‘red ﬂags’’
Concordant
4. Symptoms inconsistent with CTS require
evaluation
Concordant Some relevant content is in guideline sections that
are not speciﬁc to CTS.
5. New CTS diagnosis requires assessment of
medical risk factors
Concordant
6. New suspicion of CTS requires speciﬁc physical
examination
Concordant
7. New suspicion of CTS requires evaluation for
overweight
Not Addressed (N/A) Guideline does not explicitly link overweight/
obesity and CTS.
8. Imaging should be used selectively for suspected
CTS
Concordant
9. Symptoms should be monitored after new
diagnosis of CTS
N/A Guideline does not specify which symptoms should
be monitored at follow-up visits.
10. Splints should be placed in neutral position Concordant
11. An attempt at splinting should last at least six
weeks
Somewhat Concordant Guideline states that an attempt at splinting can last
about four weeks before steroid injections is
attempted
Certain medications should not be used for CTS
12. NSAIDs Discordant Guideline recommends NSAIDs for hand disorders
in general, states that corticosteroids may be more
effective than NSAIDs for CTS, but notes that the
side effects of steroids are a concern
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RAND/UCLA measure title Concordance with
ACOEM guideline
Comments
13. Muscle relaxants N/A Guideline does not mention the use of muscle
relaxants for CTS
14. Opioids N/A Guideline considers a short course of opiods to be an
option for hand disorders in general but does not
discuss the use of opioids for CTS
15. Diuretics N/A Guideline does not mention the use of diuretics for
CTS
16. Lasers should not be used for CTS Concordant
17. Discuss beneﬁts of surgery when offering
steroids to patients with severe CTS
N/A
18. First time steroid treatment requires discussion
of risks
N/A
19. Steroids for work-associated symptoms require
follow-up
Somewhat Concordant Guideline recommends that follow-up visits for
work-related CTS be performed at a frequency of
4–7 or 7–14 days, depending upon whether the
patient is working. The measure sets the minimum
acceptable standard for follow-up at 4 weeks after
the injection.
20. Limit steroid injections to 4 Concordant Guideline suggests steroid injections should be used
for 8-12 weeks but does not specify the number of
injections, whereas the measures specify the
number but not the total duration of use.
21. New CTS diagnosis requires detailed
occupational history
Concordant
22. New CTS diagnosis requires assessment of
occupational factors
Concordant The CTS chapter in guideline does not specify how
to assess occupational factors. The ACOEM
Return to Work Position Statement provides more
speciﬁc recommendations [69].
23. New CTS diagnosis requires assessment of non-
occupational factors
N/A Guideline does not discuss assessing non-
occupational factors that may be associated with
the CTS symptoms.
24. Exacerbating activities should be identiﬁed when
CTS limits functioning
Concordant
25. Rationale for work-association should be
documented
Concordant
26. Patients diagnosed with CTS should be educated
about the condition
Concordant Guideline is less speciﬁc about how patients should
be educated.
27. Exposures to vibration, force, and repetition
should be minimized
Somewhat Concordant Guideline mentions force and repetition but not
vibration.
28. Work-associated CTS symptoms require prompt
follow-up
Somewhat Concordant Guideline recommends that all follow-up visits for
work-related CTS be performed at a frequency of
4–7 or 7–14 days, depending upon whether the
patient is working. The measure sets the minimum
acceptable standard for follow-up frequency at
4 weeks.
29. Work status should be monitored when CTS
appears work associated
Concordant
30. Return to work after CTS-related disability
requires follow-up assessment
Somewhat Concordant Guideline does not specify a time frame for follow-
up in this speciﬁc situation. Its overall
recommended frequency for follow-up would
suggest within 4–7 days, whereas the measure sets
the minimum acceptable standard at 4 weeks after
return to work.
31. Prolonged CTS-related disability should trigger
evaluation
Concordant
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work after being on disability, physicians should identify
and, when possible, treat any issues that may be interfering
with recovery. Medical conditions that prior studies have
identiﬁed as risk factors for delayed recovery among CTS
patients include alcohol use, depression or anxiety, obesity,
and smoking; although ﬁndings are not consistent across
published studies [98, 99, 101–103]. Alcohol abuse and
substance abuse are common and serious health problems
that are challenging to detect, and the beneﬁts of identi-
fying them extend beyond facilitating return to work [104].
ACOEM guidelines and the position statement argue
that healthcare providers can and should identify and
intervene for other types of barriers to return to work
[82, 100, 105].
Comparison with Occupational Medicine Guidelines
The table below compares the RAND/UCLA CTS mea-
sures with the ACOEM guideline [49]. As seen in the table,
17 measures (55%) are fully concordant, ﬁve are somewhat
concordant (16%), the ACOEM guideline did not address
content within eight of the measures (26%), and one
measure is discordant with the guideline (3%). The mea-
sure that is discordant addresses the use of non-steroidal
anti-inﬂammatory agents, for which recent literature has
identiﬁed new risks. The RAND/UCLA measures are also
largely concordant with a CTS guideline by the American
Academy for Orthopedic Surgeons, although this guideline
is much less detailed with respect to occupational issues
[106, 107]. Table 4.
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